Immunomodulatory Effects of RAAS Inhibitors: Beyond Hypertension and Heart Failure
The renin–angiotensin–aldosterone system (RAAS) plays a central role in cardiovascular and renal homeostasis and is increasingly recognized for its broad immunomodulatory effects. Pharmacological RAAS inhibition, primarily via angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor...
Saved in:
| Main Authors: | Raluca Ecaterina Haliga, Elena Cojocaru, Oana Sîrbu, Ilinca Hrițcu, Raluca Elena Alexa, Ioana Bianca Haliga, Victorița Șorodoc, Adorata Elena Coman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/7/1779 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modulation of RAAS receptors and miRNAs in COVID-19: implications for disease severity, immune response, and potential therapeutic targets
by: Thais Freitas Barreto Fernandes, et al.
Published: (2025-03-01) -
Effectiveness and safety of glucocorticoid combined with RAAS inhibitors for treatment of IgA nephropathy
by: ZHOU Ying, et al.
Published: (2020-01-01) -
The I/D variant of the ACE gene affects the clinical characteristics of COVID-19 course in intensive care unit patients
by: Valeriy Pokhylko, et al.
Published: (2025-12-01) -
Effects of RAAS blockade on acute kidney injury in head and neck cancer patients post-chemoradiotherapy
by: Yi-Ting Chen, et al.
Published: (2025-06-01) -
Development and Validation of RAA-CRISPR/Cas12a-Based Assay for Detecting Porcine Rotavirus
by: Siyu Huang, et al.
Published: (2024-11-01)